Published in

Springer (part of Springer Nature), Acta Diabetologica, 4(52), p. 633-638

DOI: 10.1007/s00592-015-0743-y

Links

Tools

Export citation

Search in Google Scholar

Screening of glucose metabolism derangements in pediatric cystic fibrosis patients: how, when, why

Journal article published in 2015 by Adriana Franzese, E. Mozzillo, V. Fattorusso, V. Raia, G. Valerio ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Diabetes mellitus is the most common comorbidity in cystic fibrosis (CF), occurring in a variable number of children and adolescents. Glucose metabolism derangements (GMDs) are responsible for a negative impact on the general health status of CF patients. Screening of GMDs is important since the youngest age and should be performed by means of OGTT, including its intermediate times, that could detect other non-traditional GMDs. Insulin treatment, administered before overt diabetes, could be beneficial in reducing the number of pulmonary infections, in improving both pulmonary function and nutritional status. Early screening of GMDs in pediatric age can exert an important preventing role regarding all aspects of health status of patients with CF.